Abcam Inc.

Waltham, MA

UEI
CCKFL5P2M9X3
CAGE
489Q0
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
THE GAUGE, 152 Grove St Bldg 1100, Waltham, MA 02453, USA
Website
abcam.com
Founded
1998
Employees
1K-5K
Estimated annual revenue
$250M-$500M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $164,149
FY2024 -$2
FY2023 $62,143

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Similar vendors

About the company

Abcam Inc. is a foreign-owned, for-profit manufacturer of biological research products headquartered in Waltham, Massachusetts. The company is registered in SAM.gov and specializes in providing specialized scientific research materials to federal agencies, with a primary focus on producing high-quality research supplies such as antibodies, ELISA kits, and other molecular biology reagents. Abcam serves multiple federal research institutions, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the U.S. Environmental Protection Agency, delivering critical scientific research materials that support advanced medical and scientific research initiatives.

Through its federal contract awards, Abcam has consistently provided a wide range of specialized research materials, predominantly ELISA kits and monoclonal antibody supplies to various federal agencies. The majority of its contract awards have been purchase orders from NIH-related institutes, including the National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute on Aging, and National Institute of Child Health and Human Development. The contracts typically involve supplying specific research reagents such as Factor XIII ELISA kits, complement factor H ELISA kits, mouse monoclonal supplies, and antibody reagent kits. These contracts are consistently awarded as firm fixed-price purchase orders, with values ranging from approximately $11,000 to $90,864, and are not set aside for any specific business type. Abcam has demonstrated capabilities in supporting complex genomic and molecular research initiatives through its diverse product offerings.

In terms of grant-related activities, Abcam has participated in research initiatives through its subsidiary AxiomX, engaging in specialized research support services. For instance, in a February 2022 federal grant sub-award, the AxiomX team was tasked with designing peptides for producing anti-splice-specific antibodies, identifying these antibodies using proprietary methods and technologies, and providing them to other project groups. The team also performed ELISA and Western analysis from cell lysates and contributed to data analysis and manuscript preparation for molecular typing and genomics research. While the provided data shows limited grant sub-award information, it indicates Abcam's capability to provide advanced scientific research support beyond traditional product supply, emphasizing their role in supporting cutting-edge molecular and genomic research initiatives.

Quick answers

Is Abcam Inc. registered in SAM.gov?

Yes. Abcam Inc.'s SAM.gov registration is active through May 4, 2027.

How much has Abcam Inc. received in federal contracts?

Federal contracts obligated $164,149 to Abcam Inc. in fiscal year 2025 and $226,290 in fiscal years 2023 through 2027.

How does Abcam Inc. rank among federal contractors?

Abcam Inc. ranked #47 in NAICS 325414 and #72 in PSC 6550 in FY2025.

What is Abcam Inc.'s most recent federal award?

Abcam Inc.'s most recent federal contract award is [25-014448] NIH nhlbi johnson lab requires FXI elisa kits and wash buffer in order to perform elisa analysis on… (75N92025P00363), from National Heart Lung and Blood Institute (NIH), on September 9, 2025.

On GovTribe

See Abcam Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors